Rubicon OrganicsROMJF +3.17%52 Return-on-Tangible-Asset is -17.22% as of Mar. 2026. GuruFocus rates ROMJF with a GF Score™ of 52/100 and a GF Value™ of $0.36 (Fairly Valued). The stock has 2 warning signs investors should review. Among 1,004 Drug Manufacturers companies, Rubicon Organics ranks worse than 68.73% on this metric.
Return-on-Tangible-Asset is calculated as Net Income divided by its average total tangible assets. Total tangible assets equals to Total Assets minus Intangible Assets. Rubicon Organics's annualizedNet Income for the quarter that ended in Mar. 2026 was $-8.02 Mil. Rubicon Organics's average total tangible assets for the quarter that ended in Mar. 2026 was $46.59 Mil. Therefore, Rubicon Organics's annualized Return-on-Tangible-Asset for the quarter that ended in Mar. 2026 was -17.22%.
The historical rank and industry rank for Rubicon Organics's Return-on-Tangible-Asset or its related term are showing as below:
ROMJF'
s Return-on-Tangible-Asset Range Over the Past 10 Years
Min: -128.54 Med: -28.43 Max: 1.77
Current: -2.27
During the past 10 years, Rubicon Organics's highest Return-on-Tangible-Asset was 1.77%. The lowest was -128.54%. And the median was -28.43%.
ROMJF's Return-on-Tangible-Asset is ranked worse than 68.73% of 1004
companies
in the Drug Manufacturers industry
Industry Median: 3.155
vs ROMJF: -2.27
Return-on-Tangible-Asset measures the rate of return on the average total tangible assets (total assets minus intangible assets). Tangible means physical in nature. Intangible Assets are assets that are not physical in nature, and typically "derive their value from legal or intellectual rights." Return-on-Tangible-Asset measures a firm's efficiency at generating profits from its tangible assets. It shows how well a company uses what it has to generate earnings. Return-on-Tangible-Assets can vary drastically across industries. Therefore, Return-on-Tangible-Asset should not be used to compare companies in different industries.
Be Aware
Like ROE and ROA, Return-on-Tangible-Asset is calculated with only 12 months data. Fluctuations in the companys earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. Return-on-Tangible-Asset can be affected by events such as stock buyback or issuance, and by a companys tax rate and its interest payment. Return-on-Tangible-Asset may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).
Many analysts argue the higher return the better. Buffett states that really high Return-on-Tangible-Asset may indicate vulnerability in the durability of the competitive advantage.
Rubicon Organics Return-on-Tangible-Asset Related Terms
Rubicon Organics Return-on-Tangible-Asset Historical Data
* Premium members only.
The historical data trend for Rubicon Organics's Return-on-Tangible-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ROMJF vs ZTS, UTHR: Return-on-Tangible-Asset Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Rubicon Organics's Return-on-Tangible-Asset, along with its competitors' market caps and Return-on-Tangible-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Rubicon Organics Return-on-Tangible-Asset vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Rubicon Organics's Return-on-Tangible-Asset distribution charts can be found below:
* The bar in red indicates where Rubicon Organics's Return-on-Tangible-Asset falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Asset, the net income of the last fiscal year and the average total tangible assets over the fiscal year are used. In calculating the quarterly data,
the Net Income data used here is four times the quarterly (Mar. 2026) net income data.
What does a Return-on-Tangible-Asset of -17.22% mean?
Rubicon Organics (ROMJF) has a Return-on-Tangible-Asset of -17.22% as of Mar. 2026. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on Rubicon Organics and its competitors. According to the industry distribution chart, Rubicon Organics ranks #690 out of 1004 companies in the Drug Manufacturers industry, placing it in the top 68.7%.
Is Rubicon Organics' Return-on-Tangible-Asset too high?
Rubicon Organics' current Return-on-Tangible-Asset is -17.22%. Based on the distribution chart, Rubicon Organics ranks #690 out of 1004 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Rubicon Organics has a GF Score™ of 52/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Rubicon Organics' Return-on-Tangible-Asset compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Rubicon Organics ranks #690 out of 1004 companies for Return-on-Tangible-Asset. This places Rubicon Organics in the lower half of its industry. The industry median Return-on-Tangible-Asset is 3.16. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Asset for a Drug Manufacturers company?
The median Return-on-Tangible-Asset among Drug Manufacturers companies is 3.16, based on 1,004 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Asset significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Asset mean?
A high Return-on-Tangible-Asset can signal that a stock is expensive relative to its fundamentals. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on Rubicon Organics and its competitors. For the Drug Manufacturers industry, the median Return-on-Tangible-Asset is 3.16 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Rubicon Organics's current Return-on-Tangible-Asset is -17.22%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Rubicon Organics stock overvalued right now?
Based on GuruFocus' analysis, Rubicon Organics (ROMJF) is currently considered Fairly Valued. The stock's GF Value™ is $0.36, compared to a current price of $0.33 — trading 8.4% below its estimated fair value. The current Return-on-Tangible-Asset is -17.22%. Rubicon Organics' overall GF Score™ is 52/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Asset calculated?
Return-on-Tangible-Asset is calculated from a company's financial statements. For Rubicon Organics (ROMJF), the current Return-on-Tangible-Asset is -17.22% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Rubicon Organics (ROMJF) Overvalued in 2026?
Based on GuruFocus' analysis, Rubicon Organics stock appears to be undervalued.
The current stock price of $0.33 is trading 8.4% below its estimated GF Value™ of $0.36.
GuruFocus considers Rubicon Organics to be Fairly Valued.
Key valuation signals for ROMJF:
Return-on-Tangible-Asset: -17.22%
GF Value™: $0.36 vs. price of $0.33 (8.4% below fair value)
No single metric tells the full story. See the ROMJF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Rubicon Organics Inc is engaged in the production and sale of cannabis in Canada. The company produces and processes organic cannabis at its wholly owned, federally licensed 125,000 square foot facility in Delta, British Columbia which it sells under its wholly owned brands and certain wholesale channels. Its brands include Simply Bare, 1964 Supply Co, Wildflower, and Homestead Cannabis Supply. It operates in a single reportable segment, being the production and sale of cannabis in Canada.
52GF Score
Get the complete analysis for ROMJF
Return-on-Tangible-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROMJF has been successfully added to your 
